Mercaptopurine Tablets USP, 50 mg, 25 count bottle, Rx only, Roxanne Laboratories, Inc., Columbus...

FDA Drug Recall #D-1314-2014 — Class III — April 4, 2014

Recall Summary

Recall Number D-1314-2014
Classification Class III — Low risk
Date Initiated April 4, 2014
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Boehringer Ingelheim Roxane Inc
Location Columbus, OH
Product Type Drugs
Quantity 98,560 bottles

Product Description

Mercaptopurine Tablets USP, 50 mg, 25 count bottle, Rx only, Roxanne Laboratories, Inc., Columbus, Ohio, 43216, NDC 0054-4581-11

Reason for Recall

Labeling: Incorrect or Missing Lot and/or Exp Date: This recall is being conducted because the product was given 36 month expiration dates instead of the filed 24 months.

Distribution Pattern

Nationwide

Lot / Code Information

Lot 261997A Exp 02/16; 262214V, 359283V Exp. 05/16

Other Recalls from Boehringer Ingelheim Roxane Inc

Recall # Classification Product Date
D-0012-2016 Class III FUROSEMIDE Tablets USP, 40 mg, 1000-count bottl... Sep 25, 2015
D-0011-2016 Class III FUROSEMIDE Tablets USP, 20 mg, 1000-count bottl... Sep 25, 2015
D-1279-2015 Class II COMBIVENT RESPIMAT (ipratropium bromide and alb... Jul 24, 2015
D-1085-2015 Class II Acarbose Tablets 50 mg a)10 x 10 Unit Dose Tabl... Apr 2, 2015
D-1486-2014 Class III OXYCODONE HYDROCHLORIDE C II Oral Solution USP,... Jul 28, 2014

Frequently Asked Questions

Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.